Area of research
Hematology · Oncology
Research interest
Research interests include Multiple Myeloma Research and Treatments, CAR-T cell therapy research, Protein Degradation and Inhibitors, and Peptidase Inhibition and Analysis.
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells
Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study
Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma
BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement
Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma
Updated Safety and Efficacy Results of Abbv-383, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in a First-in-Human Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma